| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0058 | 1 |